Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil vs Cyclosporin in High Risk Membranous Nephropathy
NCT01282073Phase 3Completed
- Sponsor
- Kyungpook National University Hospital
- Start
- Mar 2011
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in idiopathic membranous nephropathy (IMN), sponsored by Kyungpook National University Hospital. Started Mar 2011; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
idiopathic membranous nephropathy (IMN)
Beyond the preview
Go deeper on NCT01282073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01282073.